Moreover, ERRFI1 can be targeted for degradation by miRNA, such as miRNA-148 and miRNA-200, which have been shown to target ERRFI1 in glioblastomas and bladder cancer, respectively (81,83). This evidence concerns the gene ERRFI1 and urinary bladder carcinoma.